Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
| Prif Awdur: | |
|---|---|
| Awduron Eraill: | |
| Fformat: | Traethawd Ymchwil |
| Iaith: | English |
| Cyhoeddwyd: |
Brac University
2024
|
| Pynciau: | |
| Mynediad Ar-lein: | http://hdl.handle.net/10361/22174 |
| id |
10361-22174 |
|---|---|
| record_format |
dspace |
| spelling |
10361-221742024-01-17T21:02:35Z Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer Rahman, Tasnim Azam, Faruque School of Pharmacy, Brac University Efficacy endpoint Clinical trial Treatment size Lung cancer Lung--Cancer--Treatment This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023. Cataloged from PDF version of thesis. Includes bibliographical references (page 16). In spite of recent developments in cancer therapy that are specifically targeted, a frightening number of individuals still pass away every year from lung cancer around the world. Because of this, we decided to focus our research on non-small cell lung cancer. As a consequence of the high degree of heterogeneity that characterizes lung carcinoma, the unsatisfied clinical need is the determination of a suitable combination of medications. The requirement for the validation of efficacy endpoint methods in clinical trials, which are methods by which the effectiveness of cancer medicines is determined, is one possible cause of the problem that was described above. We intend to help investigators design clinical trials by establishing two predictive efficacy models, and we plan to optimize the combination treatment for certain lung malignancies by examining a substantial amount of clinical trial efficacy data. This will allow us to do both. Tasnim Rahman B. Pharmacy 2024-01-17T04:50:46Z 2024-01-17T04:50:46Z 2023 2023-03 Thesis ID 18346019 http://hdl.handle.net/10361/22174 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 38 pages application/pdf Brac University |
| institution |
Brac University |
| collection |
Institutional Repository |
| language |
English |
| topic |
Efficacy endpoint Clinical trial Treatment size Lung cancer Lung--Cancer--Treatment |
| spellingShingle |
Efficacy endpoint Clinical trial Treatment size Lung cancer Lung--Cancer--Treatment Rahman, Tasnim Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer |
| description |
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023. |
| author2 |
Azam, Faruque |
| author_facet |
Azam, Faruque Rahman, Tasnim |
| format |
Thesis |
| author |
Rahman, Tasnim |
| author_sort |
Rahman, Tasnim |
| title |
Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer |
| title_short |
Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer |
| title_full |
Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer |
| title_fullStr |
Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer |
| title_full_unstemmed |
Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer |
| title_sort |
impact of treatment size and therapy type in phase ii clinical trials of non-small cell lung cancer |
| publisher |
Brac University |
| publishDate |
2024 |
| url |
http://hdl.handle.net/10361/22174 |
| work_keys_str_mv |
AT rahmantasnim impactoftreatmentsizeandtherapytypeinphaseiiclinicaltrialsofnonsmallcelllungcancer |
| _version_ |
1814308021421998080 |